Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients

HLA

Volumn 87, Issue 1, 2016, Pages 13-18

  Paradowska Gorycka, A ^a   Stypinska B ^a   Olesinska M ^b   Felis Giemza, A ^b   Manczak M ^a   Czuszynska, Z ^c   Zdrojewski, Z ^c   Wojciechowicz, J ^d   Jurkowska, M ^a  

^a National Institute of Geriatrics   (Poland)

^b NATIONAL INSTITUTE OF GERIATRICS   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d DNA Research Centre   (Poland)

Author keywords

Association study; Genetics; HLA; Humans; Mixed connective tissue disease

Indexed keywords

HLA DRB1 ANTIGEN; AUTOANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HLA DRB1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLAND; ARTHRITIS, RHEUMATOID; BLOOD; CASE CONTROL STUDY; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENETICS; HETEROZYGOTE; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOLOGY; REGISTER; SCLERODERMA, SYSTEMIC;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HLA-DRB1 CHAINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLAND; REGISTRIES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SCLERODERMA, SYSTEMIC;

EID: 84949032163     PISSN: 20592302     EISSN: 20592310     Source Type: Journal    
DOI: 10.1111/tan.12698     Document Type: Article

References (33)

1. Venables PJ. Mixed connective tissue disease. Lupus 2006: 15: 132-7.
2. Winfield JB, Koffler D, Kunkel HG. Development of antibodies to ribonucleoprotein following short-term therapy with procainamide. Arthritis Rheum 1975: 18: 531-4.
3. Szodoray P, Szollosi Z, Gyimesi E et al. Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations. Rheumatol Int 2008: 28: 743-7.
4. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972: 52: 148-59.
5. Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 2012: 26: 61-72.
6. Li J, Wang X, Zhang F et al. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol Ther 2013: 138: 441-51.
7. Chauhan SK, Singh VV, Rai R et al. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol 2013: 33: 954-64.
8. Celhar T, Magalhaes R, Fairhurst AM. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res 2012: 53: 58-77.
9. Minkin W, Rabhan N. Mixed connective tissue disease. Arch Dermatol 1976: 112: 1535-8.
10. Malmegrim KC, Pruijn GJ, van Venrooij WJ. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity. Isr Med Assoc J 2002: 4: 706-12.
11. Aringer M, Smolen JS. Mixed connective tissue disease: what is behind the curtain? Best Pract Res Clin Rheumatol 2007: 21: 1037-49.
12. Swanton J, Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin N Am 2005: 31: 421-36.
13. Smolen JS, Steiner G. Mixed connective tissue disease. To be or not to be? Arthritis Rheum 1998: 41: 768-77.
14. Hassan AB, Nikitina-Zake L, Padyukov L et al. MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Hum Immunol 2003: 64: 290-6.
15. Flåm ST, Gunnarsson R, Garen T et al. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatology (Oxford) 2015: 54: 528-35.
16. Bodolay E, Aleksza M, Antal-Szalmas P et al. Serum cytokine levels and type 1 and type 2 intracellular t cell cytokine profiles in mixed connective tissue disease. J Rheumatol 2002: 29: 2136-42.
17. Fenning S, Wolff-Vorbeck G, Hackl W et al. T cell lines recognizing the 70-kD protein of U1 small nuclear ribonucleoprotein (U1snRNP). Clin Exp Immunol 1995: 101: 408-13.
18. Talken BL, Bailey CW, Reardon SL, Caldwell CW, Hoffman RW. Structural analysis of TCRα and β chains from human T-cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70kDa: TCR complementarity determining region 3 usages appears highly conserved. Scan J Immunol 2001: 54: 204-10.
19. Greidinger EL, Foecking MF, Schafermeyer KR et al. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J Immunol 2002: 169: 3429-37.
20. Hof D, Cheung K, RAM de Rooij DJ et al. Antibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res Ther 2005: 7: R302-9.
21. Mamula MJ, Gee RJ, Elliot JI et al. Isoaspartyl post-translation modification triggers autoimmune responses to self-proteins. J Biol Chem 1999: 274: 22321-7.
22. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam: Elsevier, 1987, 41-7.
23. Greidinger EL, Zang YJ, Jaimes K, Martinez L, Nassiri M, Hoffman RW. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J Immunol 2008: 180: 8444-54.
24. Sayer DC, Whidborne R, De Santis D et al. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB 3, 4, 5. Tissue Antigens 2004: 63: 412-23.
25. Cano P, Klitz W, Mack SJ et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatibility and immunogenetics. Hum Immunol 2007: 68: 392-417.
26. Schmidt AH1, Solloch UV, Pingel J et al. High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20, 653 stem cell donors. Hum Immunol 2011: 72: 558-65.
27. Nowak J, Mika-Witkowska R, Polak M et al. Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. Tissue Antigens 2008: 71: 193-205.
28. Hoffman RW, Maldonado ME. Immune pathogenesis of mixed connective tissue disease: a short analytical review. Clin Immunol 2008: 128: 8-17.
29. Dong RP, Kimura A, Hashimoto H, Akizuki M, Nishimura Y, Sasazuki T. Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 1993: 41: 20-5.
30. Hassan AB, Nikitina-Zake L, Padyukov L et al. MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Hum Immunol 2003: 64: 290-6.
31. Yoshida K, Inoue H, Komai K et al. Mixed connective tissue disease is distinct from systemic lupus erythematosus: study of major histocompatibility complex class I polypeptide-related sequence A and HLA gene polymorphisms. Tissue Antigens 2013: 81: 44-5.
32. Weckmann AL, Granados J, Cardiel MH et al. Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population. Clin Exp Rheumatol 1999: 17: 91-4.
33. Burdt MA, Hoffman RW, Deutscher SL et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999: 42: 899-909.